Anticarcinogenic and antigenotoxic effects of Bacillus polyfermenticus

Journal of Microbiology and Biotechnology

Volumn 14, Issue 4, 2004, Pages 852-858

  Park, Eunju ^c   Kim, Kee Tae ^a   Kim, Cheon Jei ^b   Kim, Chang Han ^b   Paik, Hyun Dong ^b  

^a Proco Biotech Co   (South Korea)

^b Konkuk University   (South Korea)

^c Kyungnam University   (South Korea)

Author keywords

Anticarcinogenic; Antigenotoxic; Bacillus polyfermenticus SCD; Colon cancer; Comet assay; DNA damage; MIT assay

Indexed keywords

ETHYLNITRONITROSOGUANIDINE; PROBIOTIC AGENT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACILLUS; BACILLUS POLYFERMENTICUS; CANCER CELL; CANCER MORTALITY; CELL PROLIFERATION; CELL PROTECTION; CELL STRAIN; COLON CANCER; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; EATING HABIT; GENOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LACTIC ACID BACTERIUM; LYMPHOCYTE; MORBIDITY; NONHUMAN;

BACILLUS POLYFERMENTICUS;

EID: 4444351566     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Abdelali, H., P. Cassand, V. Soussotte, B. Koch-Bocabeille, and J. F. Narbonne. 1995. Antimutagenicity of components of dairy products. Mutat. Res. 331: 133-141.
2. Baricault, L., G. Denariaz, J. J. Houri, C. Bouley, C. Sapin, and G. Trugnan. 1995. Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis 16: 245-252.
3. Benno, Y. and T. Mitsuoka. 1992. Impact of Bifidobacterium longum on human fecal microflora. Microbiol. Immunol. 36: 683-694.
4. Bingham, S. A., B. Pignatelli, J. R. Pollock, A. Ellul, C. Malaveille, G. Gross, S. Runswick, J. H. Cummings, and I. K. O'Neill. 1996. Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis 17: 515-523.
5. Bolognani, F., C. J. Rumney, B. L. Pool-Zobel, and I. R. Rowland. 2001. Effect of lactobacilli, bifidobacteria and inulin on the formation of aberrant crypt foci in rats. Eur. J. Nutr. 40: 293-300.
6. Brady, L. J., D. D. Gallaher, and F. F. Busta. 2000. The role of probiotic cultures in the prevention of colon cancer. J. Nutr. 130: 410S-414S.
7. Femia, A. P., C. Luceri, P. Dolara, A. Giannini, A. Biggeri, M. Salvadori, Y. Clune, K. J. Collins, M. Paglierani, and G. Caderni. 2002. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23: 1953-1960.
8. Han, B.-J., S.-K. Woo, and H.-K. Shin. 1995. Effects of the water extract of Akebia on the growth of Clostridium perfringens and some intestinal microorganism. Kor. J. Appl. Microbiol. Biotechnol. 23: 633-640.
9. Hansen, M. B., S. E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119: 203-210.
10. Hosoda, M., H. Hashimoto, H. Morita, M. Chiba, and A. Hosono. 1992. Antimutagenicity of milk cultured with lactic acid bacteria against N-methyl-N′-nitro-N-nitrosoguanidine. J. Dairy Sci. 75: 976-981.
11. Hosono, A., T. Tanabe, and H. Otani. 1990. Binding properties of lactic acid bacteria from kefir milk with mutagenic amino acid pyrolyzates. Milchwissenschaft 45: 647-651.
12. Ji, B. T., S. S. Devesa, W. H. Chow, F. Jin, and Y. T. Gao. 1998. Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994. Cancer Epidemiol. Biomarkers Prev. 7: 661-666.
13. Ji, S.-T., J.-H. Park, O.-B. Choi, C.-K. Hyun, and H.-K. Shin. 1999. Antigenotoxic effect of lactic acid bacteria in vitro in the primary colon cells of Sprague-Dawley-Rats. Kor. J. Food Sci. Anim. Resour. 19: 10-18.
14. Johnson, I. T., G. Williamson, and S. R. R. Musk. 1994. Anticarcinogenic factors in plant food: A new class of nutrients? Nutr. Res. Rev. 7: 175-204.
15. Jun, K.-D., K.-H. Lee, W.-S. Kim, and H.-D. Paik. 2000. Microbiological identification of medical probiotic bispan strain. J. Kor. Soc. Food Sci. Nutr. 28: 124-127.
16. Kim, J. Y., H. J. Woo, K. H. Kim, E.-R. Kim, H.-K. Jung, H.-N. Juhn, and H. J. Lee. 2002. Antitumor activity of Lactobacillus plantarum cytoplasm on teratocarcinoma bearing mice. J. Microbiol. Biotechnol. 12: 998-1001.
17. Kopp-Hoolihan, L. 2001. Prophylactic and therapeutic uses of probiotics: A review. J. Am. Diet Assoc. 101: 229-238.
18. Lee, K.-H., K.-D. Jun, W.-S. Kim, and H.-D. Paik. 2001. Partial characterization of polyfermenticin SCD, a newly identified bacteriocin of Bacillus polyfermenticus. Lett. Appl. Microbiol. 32: 146-151.
19. Mombelli, B. and M. R. Gismondo. 2000. The use of probiotics in medical practice. Int. J. Antimicrob. Agents 16: 531-536.
20. Park, K.-Y., H.-Y. Jung, K.-L. Woo, K.-D. Jun, J.-S. Kang, and H.-D. Paik. 2002. Effects of Bacillus polyfermenticus SCD administration on fecal microflora and putrefactive metabolites in healthy adults. J. Microbiol. Biotechnol. 12: 657-663.
21. Pool-Zobel, B. L., B. Bertram, M. Knoll, R. Lambertz, C. Neudecker, U. Schillinger, P. Schmezer, and W. H. Holzapfel. 1993. Antigenotoxic properties of lactic acid bacteria in vivo in the gastrointestinal tract of rats. Nutr. Cancer 20: 271-281.
22. Reid, G., M. E. Sanders, H. R. Gaskins, G. R. Gibson, A. Mercenier, R. Rastall, M. Roberfroid, I. Rowland, C. Cherbut, and T. R. Klaenhammer. 2003. New scientific paradigms for probiotics and prebiotics. J. Clin. Gastroenterol. 37: 105-118.
23. Shin, M.-S., Y.-J. Kim, H-S. Bae, and Y.-J. Baek. 1996. Effects of the lactic acid bacteria administration on fecal microflora and putrefactive metabolites in healthy adults. Kor. J. Appl. Microbiol. Biotechnol. 24: 254-260.
24. Singh, P. N., M. T. McCoy, R. R. Tice, and E. L. Schneider. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell. Res. 175: 184-191.
25. Slater, T. F., B. Sawyer, and U. Straeuli. 1963. Studies on succinate-tetrazolium reductase systems. III. Points of coupling of four different tetrazolium salts. Biochim. Biophys. Acta 77: 383-393.
26. Surh, Y.-J. 1999. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 428: 305-327.